Aim:

To access beta-endorphin levels in serum as well as seminal plasma in different infertile male groups.

Methods:

Beta-endorphin was estimated in the serum and seminal plasma by enzyme-linked immunosorbent assay (ELISA) method in 80 infertile men equally divided into four groups: non-obstructive azoospermia (NOA), obstructive azoospermia (OA), congenital bilateral absent vas deferens (CBVAD) and asthenozoospermia. The results were compared to those of 20 normozoospermic proven fertile men.

Results:

There was a decrease in the mean levels of beta-endorphin in the seminal plasma of all successive infertile groups (mean SD: NOA 51.30 27.37, OA 51.88 9.47, CBAVD 20.36 13.39, asthenozoospermia 49.26 12.49 pg/mL, respectively) compared to the normozoospermic fertile control (87.23 29.55 pg/mL). This relation was not present in mean serum level of beta-endorphin between four infertile groups (51.09 14.71, 49.76 12.4, 33.96 7.2, 69.1 16.57 pg/mL, respectively) and the fertile control group (49.26 31.32 pg/mL). The CBVAD group showed the lowest seminal plasma mean level of beta-endorphin. Testicular contribution of seminal beta-endorphin was estimated to be approximately 40%. Seminal beta-endorphin showed significant correlation with the sperm concentration (r = 0.699, P = 0.0188) and nonsignificant correlation with its serum level (r = 0.375, P = 0.185) or with the sperm motility percentage (r = 0.470, P = 0.899).

Conclusion:

The estimation of beta-endorphin alone is not conclusive to evaluate male reproduction as there are many other opiates acting at the hypothalamic pituitary gonadal axis.

References

1. Morales Martinez ME, Pedron N. Beta-endorphins and the male reproductive system. Ginecol Obstet Mex 1999; 67: 183–7. | PubMed | ChemPort |
2. Sharp B, Pekary AE. Beta-Endorphin 16–91 and other beta-endorphin-immunoreactive peptides in human semen. J Clin Endocrinol Metab 1981; 52: 586–8. | PubMed | ChemPort |
3. Fraioli F, Fabbri A, Gnessi L, Silvestroni L, Moretti C, Redi F, et al. Beta-endorphin, Metenkephalin and calcitonin in human semen: evidence for a possible role in human sperm motility. Ann N Y Acad Sci 1984; 438: 365–70. | Article | PubMed | ChemPort |
4. Miralles-Garcia JM, Mories-Alvarez MT, Corrales-Hernandez JJ, Garcia-Diez CL. Beta-endorphin and male infertility. Arch Androl 1986; 16: 247–51. | Article | PubMed | ChemPort |
5. Bardin CW, Chen CL, Morris PL, Gerendai I, Boitani C, Liotta AS, et al. Proopiomelanocortin-derived peptides in testis, ovary and tissues of reproduction. Recent Prog Horm Res 1987; 43:1–28. | PubMed | ChemPort |
6. Huleihel M, Lunenfeld E. Regulation of spermatogenesis by paracrine/autocrine testicular factors. Asian J Androl 2004; 6: 259–68. | PubMed | ChemPort |
7. Zalata A, Hafez T, Van Hoecke MJ, Comhaire F. Evaluation of beta-endorphin and interleukin-6 in seminal plasma of patients with certain andrological diseases. Hum Reprod 1995; 10: 3161–5. | PubMed | ChemPort |
8. Shaha C, Liotta AS, Krieger DT, Bardin CW. The ontogeny of immunoreactive beta-endorphin in fetal, neonatal and pubertal tes-tes from mouse and hamster. Endocrinology 1984; 114: 1584–91. | PubMed | ChemPort |
9. Chen CL, Mather JP, Morris PL, Bardin CW. Expression of pro- opiomelanocortin-like gene in the testis and epididymis. Proc Natl Acad Sci U S A 1984; 81: 5672–5. | Article | PubMed | ChemPort |
10. WHO Laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4th ed. Cambridge: Cambridge University Press; 1999.
11. Fabbri A, Fraioli F, Isidori A. Opioid peptides in the testis and the male genital tract: presence and possible function. J Endocrinol Invest 1986; 9: 521–8. | PubMed | ChemPort |
12. Fabbri A, Jannini EA, Gnessi L, Ulisse S, Moretti C, Isidori A. Neuroendocrine control of male reproductive function. The opioid system as a model of control at multiple sites. J Steroid Biochem 1989; 32: 145–50. | Article | PubMed | ChemPort |
13. Singer R, Bruchis S, Barnet M, Sagiv M, Kaufman H, Servadio C. Beta-endorphin in normozoospermic and pathologic human semen. Experientia 1985; 41: 64–5. | Article | PubMed | ChemPort |
14. Delitala G, Manelli M, Gusti M, Serio M. Relation of opiates to hormonal secretion in man. In: Delitala G, Motta M, Serio M, editors. Opioid Modulation of Endocrine Function. New York: Raven Press; 1984. p 65.
15. Foresta C, Irdino M, Federspil G, Scandellari C. Dopamine is not involved in the opioid control of luteinizing hormone secretion in man. Fertil Steril 1985; 44: 504–7. | PubMed | ChemPort |
16. Sirinathsinghji DJ, Rees LH, Rivier J, Vale W. Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature 1983; 305: 232–5. | Article | PubMed | ISI | ChemPort |
17. Petraglia F, Sutton S, Vale W, Plotsky P. Corticotropin-re-leasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation. Endocrinology 1987; 120: 1083–8. | PubMed | ChemPort |
18. Ragni G, De Lauretis L, Bestetti O, Sghedoni D, Gambaro V. Gonadal function in male heroin and methadone addicts. Int J Androl. 1988; 11: 93–100. | Article | PubMed | ChemPort |
19. Graczykowski JW, Vermesh M, Siegel MS, Davidson A, Lobo RA. Absence of direct effect of beta-endorphin and calcitonin on human sperm motility. Arch Androl 1990; 24: 121–4. | Article | PubMed | ChemPort |
20. Singer R, Bruchis S, Sagiv M, Allalouf D, Levinsky H, Kaufman H. Beta-endorphin and calcitonin in human semen. Arch Androl 1989; 23: 77–81. | Article | PubMed | ChemPort |